CHARLES SCHWAB INVESTMENT MANAGEMENT INC - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 87 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2020. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q3 2023$2,259
-90.3%
11,2870.0%0.00%
Q2 2023$23,251
-37.6%
11,2870.0%0.00%
Q1 2023$37,247
+101.2%
11,2870.0%0.00%
Q4 2022$18,511
-63.0%
11,2870.0%0.00%
Q3 2022$50,000
+56.2%
11,2870.0%0.00%
Q2 2022$32,000
-15.8%
11,2870.0%0.00%
Q1 2022$38,000
-17.4%
11,2870.0%0.00%
Q4 2021$46,000
+21.1%
11,2870.0%0.00%
Q3 2021$38,000
-11.6%
11,2870.0%0.00%
Q2 2021$43,000
-85.7%
11,287
-85.6%
0.00%
Q1 2021$300,000
+1.4%
78,115
+19.7%
0.00%
Q4 2020$296,000
-75.2%
65,240
-7.6%
0.00%
-100.0%
Q3 2020$1,195,000
+54.8%
70,593
+2.6%
0.00%
Q2 2020$772,000
+1356.6%
68,781
+509.4%
0.00%
Q1 2020$53,000
+8.2%
11,2870.0%0.00%
Q4 2019$49,000
+8.9%
11,2870.0%0.00%
Q3 2019$45,0000.0%11,2870.0%0.00%
Q2 2019$45,000
-8.2%
11,2870.0%0.00%
Q1 2019$49,00011,2870.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q3 2020
NameSharesValueWeighting ↓
ABNER HERRMAN & BROCK LLC 241,500$1,093,0000.17%
OCCUDO QUANTITATIVE STRATEGIES LP 90,584$410,0000.13%
EPIQ PARTNERS, LLC 10,550$48,0000.03%
Phoenix Holdings Ltd. 173,683$799,0000.02%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 5,500$25,0000.02%
CFO4Life Group, LLC 12,003$54,0000.02%
HighPoint Advisor Group LLC 15,733$115,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 357,761$1,619,0000.01%
Virtu Financial LLC 24,484$111,0000.01%
ETF MANAGERS GROUP, LLC 93,902$435,0000.01%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders